Ryan Halsted
Stock Analyst at RBC Capital
(1.40)
# 5,150
Out of 5,182 analysts
14
Total ratings
55.56%
Success rate
-1.16%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Outperform | $522 → $484 | $421.37 | +14.86% | 2 | Apr 24, 2026 | |
| HCSG Healthcare Services Group | Maintains: Sector Perform | $22 → $24 | $21.70 | +10.60% | 2 | Apr 23, 2026 | |
| DOCS Doximity | Reiterates: Outperform | $44 | $24.66 | +78.43% | 1 | Mar 9, 2026 | |
| IQV IQVIA Holdings | Initiates: Outperform | $221 | $163.84 | +34.89% | 1 | Mar 3, 2026 | |
| MDLN Medline | Maintains: Outperform | $47 → $53 | $45.23 | +17.18% | 2 | Feb 26, 2026 | |
| EVH Evolent Health | Maintains: Sector Perform | $5 → $3 | $3.47 | -13.54% | 1 | Feb 25, 2026 | |
| PRVA Privia Health Group | Reinstates: Outperform | $31 | $24.41 | +27.00% | 1 | Jan 9, 2026 | |
| TBRG TruBridge | Reinstates: Sector Perform | $23 | $25.72 | -10.58% | 1 | Jan 9, 2026 | |
| ENSG The Ensign Group | Downgrades: Underperform | n/a | $189.94 | - | 3 | Apr 28, 2017 |
Medpace Holdings
Apr 24, 2026
Maintains: Outperform
Price Target: $522 → $484
Current: $421.37
Upside: +14.86%
Healthcare Services Group
Apr 23, 2026
Maintains: Sector Perform
Price Target: $22 → $24
Current: $21.70
Upside: +10.60%
Doximity
Mar 9, 2026
Reiterates: Outperform
Price Target: $44
Current: $24.66
Upside: +78.43%
IQVIA Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $221
Current: $163.84
Upside: +34.89%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $47 → $53
Current: $45.23
Upside: +17.18%
Evolent Health
Feb 25, 2026
Maintains: Sector Perform
Price Target: $5 → $3
Current: $3.47
Upside: -13.54%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $24.41
Upside: +27.00%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $25.72
Upside: -10.58%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $189.94
Upside: -